US$ 28.65
glp 1 direct from manufacturer Novo Nordisk, Eli Lilly roll out obesity pills, prepare for Medicare coverage GLP-1s Going Direct, How Novo
Description
Countries without their own HTA may partially defer to NICE for value benchmarks or at least consider NICEs published cost/QALY figures

If you havent optimized basics like nutrition, movement, stress, and sleepstart there

I always emphasize to my patients that its not just about the number on the scale

This is one reason generic dieting advice often falls apart

Kamba A, Daimon M, Murakami H, et al
2014;10:S12S25
